QQQ   383.17 (+0.01%)
AAPL   165.83 (+2.47%)
MSFT   322.01 (-0.31%)
FB   313.84 (+2.28%)
GOOGL   2,837.72 (-0.08%)
AMZN   3,415.46 (+0.76%)
TSLA   976.34 (-3.81%)
NVDA   292.57 (-4.68%)
BABA   120.29 (+7.44%)
NIO   31.82 (-1.03%)
CGC   9.92 (-0.70%)
AMD   136.01 (-5.56%)
GE   96.46 (+3.98%)
MU   81.96 (+0.42%)
T   23.56 (+0.43%)
F   19.19 (+0.26%)
DIS   150.04 (+2.61%)
PFE   52.27 (-3.69%)
AMC   28.37 (-2.21%)
ACB   5.84 (+0.34%)
BA   206.07 (+3.82%)
QQQ   383.17 (+0.01%)
AAPL   165.83 (+2.47%)
MSFT   322.01 (-0.31%)
FB   313.84 (+2.28%)
GOOGL   2,837.72 (-0.08%)
AMZN   3,415.46 (+0.76%)
TSLA   976.34 (-3.81%)
NVDA   292.57 (-4.68%)
BABA   120.29 (+7.44%)
NIO   31.82 (-1.03%)
CGC   9.92 (-0.70%)
AMD   136.01 (-5.56%)
GE   96.46 (+3.98%)
MU   81.96 (+0.42%)
T   23.56 (+0.43%)
F   19.19 (+0.26%)
DIS   150.04 (+2.61%)
PFE   52.27 (-3.69%)
AMC   28.37 (-2.21%)
ACB   5.84 (+0.34%)
BA   206.07 (+3.82%)
QQQ   383.17 (+0.01%)
AAPL   165.83 (+2.47%)
MSFT   322.01 (-0.31%)
FB   313.84 (+2.28%)
GOOGL   2,837.72 (-0.08%)
AMZN   3,415.46 (+0.76%)
TSLA   976.34 (-3.81%)
NVDA   292.57 (-4.68%)
BABA   120.29 (+7.44%)
NIO   31.82 (-1.03%)
CGC   9.92 (-0.70%)
AMD   136.01 (-5.56%)
GE   96.46 (+3.98%)
MU   81.96 (+0.42%)
T   23.56 (+0.43%)
F   19.19 (+0.26%)
DIS   150.04 (+2.61%)
PFE   52.27 (-3.69%)
AMC   28.37 (-2.21%)
ACB   5.84 (+0.34%)
BA   206.07 (+3.82%)
QQQ   383.17 (+0.01%)
AAPL   165.83 (+2.47%)
MSFT   322.01 (-0.31%)
FB   313.84 (+2.28%)
GOOGL   2,837.72 (-0.08%)
AMZN   3,415.46 (+0.76%)
TSLA   976.34 (-3.81%)
NVDA   292.57 (-4.68%)
BABA   120.29 (+7.44%)
NIO   31.82 (-1.03%)
CGC   9.92 (-0.70%)
AMD   136.01 (-5.56%)
GE   96.46 (+3.98%)
MU   81.96 (+0.42%)
T   23.56 (+0.43%)
F   19.19 (+0.26%)
DIS   150.04 (+2.61%)
PFE   52.27 (-3.69%)
AMC   28.37 (-2.21%)
ACB   5.84 (+0.34%)
BA   206.07 (+3.82%)
NASDAQ:ALQA

Alliqua Biomedical Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
N/A
50-Day Range
$2.20
$3.23
52-Week Range
N/A
Volume
371,516 shs
Average Volume
114,400 shs
Market Capitalization
$13.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.03

Receive ALQA News and Ratings via Email

Sign-up to receive the latest news and ratings for Alliqua Biomedical and its competitors with MarketBeat's FREE daily newsletter.


Alliqua Biomedical logo

About Alliqua Biomedical

Alliqua BioMedical, Inc. develops, manufactures, and markets high water content, electron beam cross-linked, and aqueous polymer hydrogels or gels used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It also provides contract manufacturing services to the OEM market. The company is headquartered in Langhorne, Pennsylvania.

Headlines

ADYX.PK - Adynxx Inc Key Developments | Reuters
August 17, 2020 |  reuters.com
Alliqua up 28% premarket on merger with Adynxx
April 22, 2019 |  seekingalpha.com
Alliqua BioMedical declares $1.05 dividend
April 11, 2019 |  seekingalpha.com
Alliqua BioMedical, Inc. Estimate Momentum
March 18, 2019 |  www.nasdaq.com
Alliqua files for AquaMed spinoff
January 9, 2019 |  seekingalpha.com
Alliqua Biomedical CEO Provides Update to Shareholders
January 3, 2019 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ALQA
Fax
N/A
Employees
6
Year Founded
N/A

Sales & Book Value

Annual Sales
$2.22 million
Book Value
$1.65 per share

Profitability

Net Income
$-8.42 million
Net Margins
-230.50%
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$13.46 million
Optionable
Not Optionable

Company Calendar

Last Earnings
8/09/2016
Today
12/06/2021

MarketRank

Overall MarketRank

1.17 out of 5 stars

Medical Sector

1202nd out of 1,390 stocks

Surgical & Medical Instruments Industry

116th out of 126 stocks

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -












Alliqua Biomedical (NASDAQ:ALQA) Frequently Asked Questions

How were Alliqua Biomedical's earnings last quarter?

Alliqua Biomedical Inc (NASDAQ:ALQA) issued its earnings results on Tuesday, August, 9th. The company reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of ($2.70) by $3.20. The company had revenue of $5.50 million for the quarter, compared to the consensus estimate of $5.38 million. Alliqua Biomedical had a negative trailing twelve-month return on equity of 71.73% and a negative net margin of 230.50%.
View Alliqua Biomedical's earnings history
.

When did Alliqua Biomedical's stock split? How did Alliqua Biomedical's stock split work?

Alliqua Biomedical's stock reverse split before market open on Friday, October 6th 2017. The 1-10 reverse split was announced on Thursday, October 5th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 5th 2017. An investor that had 100 shares of Alliqua Biomedical stock prior to the reverse split would have 10 shares after the split.

Who are Alliqua Biomedical's key executives?

Alliqua Biomedical's management team includes the following people:
  • Mr. David Ian Johnson, Pres, CEO, Principal Financial Officer & Director (Age 61)
  • Dr. Phillip D. Forman M.D., DPM, Exec. VP of Clinical Affairs (Age 60)
  • Mr. Joseph M. Warusz, CFO, Treasurer & Sec. (Age 63)

What other stocks do shareholders of Alliqua Biomedical own?

What is Alliqua Biomedical's stock symbol?

Alliqua Biomedical trades on the NASDAQ under the ticker symbol "ALQA."

How much money does Alliqua Biomedical make?

Alliqua Biomedical has a market capitalization of $0.00 and generates $2.22 million in revenue each year.

How many employees does Alliqua Biomedical have?

Alliqua Biomedical employs 6 workers across the globe.

What is Alliqua Biomedical's official website?

The official website for Alliqua Biomedical is www.alliqua.com.

Where are Alliqua Biomedical's headquarters?

Alliqua Biomedical is headquartered at 2150 CABOT BLVD WEST SUITE B, LANGHORNE PA, 19047.

How can I contact Alliqua Biomedical?

Alliqua Biomedical's mailing address is 2150 CABOT BLVD WEST SUITE B, LANGHORNE PA, 19047. The company can be reached via phone at 215-702-8550 or via email at [email protected].


This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.